Verastem | VSTM - Market Capitalization


Verastem reported $127.5M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alaunos Therapeutics USD 51M 46M Mar/2026
AstraZeneca USD 220.14B 68B Mar/2026
Cytokinetics USD 7.77B 1.19B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025